AzTrials
AzTrials

PrehypertensionNCT06762262

Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients

A study testing Moderate-Intensity continuous training in people with Prehypertension, run by Riphah International University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Hypertension, commonly known as high blood pressure, continues to be the leading cause of both sickness and mortality globally. Generally, individuals in good health might have trouble breathing solely during vigorous exercise or when holding their breath, finding relief by stopping the activity or adjusting their… Read more about this study

Who is it for?
Ages 45 to 75 years
Conditions the study is for
Prehypertension
What is being tested?
Moderate-Intensity continuous training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 sitePakistan
Study dates
20 Apr 2024to 30 Apr 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants must be between 45 to 70 years old
  • Gender: Male and Female both
  • Chronic, mild-to moderate, and stable (>1 year duration) hypertension (systolic blood pressure
  • [SBP] between 140-179 mm Hg and diastolic blood pressure [DBP] between 90-109 mm Hg).
  • Single antihypertensive medication will be recruited.
  • Participants have sedentary life style.
  • Smokers, alcoholic, diabetic, and other cardiac problems (controlled) would be included.

Who cannot join

  • Patients with Permanent atrial fibrillation
  • Patients with COPD
  • Patients with Heart surgery
  • Patients with presence of symptomatic congestive heart failure
  • Smokers, alcoholic, diabetic, and other cardiac, renal, and respiratory disease patients (uncontrolled) would be excluded.
  • Participants with no history of psychiatry or psychological disorders or abnormalities.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Sheikh Zaid Hospital

    Quetta, Balochistan, oooo

Other trials in Pakistan

About this study

Official title: Effects of Pilate Training Versus Moderate Intensity Continous Training on Dyspnea and Cardiovascular Fitness in Hypertensive Patients

Hypertension, commonly known as high blood pressure, continues to be the leading cause of both sickness and mortality globally. Generally, individuals in good health might have trouble breathing solely during vigorous exercise or when holding their breath, finding relief by stopping the activity or adjusting their breathing technique. Often patients with hypertension seek various treatments to relieve symptoms. The aim of this study is to compare the effects of Pilates Training and Moderate Intensity Continuous Training on dyspnea and cardiovascular fitness in hypertensive patients. The study would be randomized clinical trial. A total of thirty-four subjects will be assigned randomly by using block randomization into two groups. Group A will be given Pilates training while Group B will moderate intensity training. After confirmation of diagnosis with medical history and physical examination as well as chronic, mild-to moderate, and stable (>1 year duration) hypertension (systolic blood pressure [SBP] between 140-179 mm Hg and diastolic blood pressure [DBP]between 90-109 mm Hg) recommended. 3-minute step test, VO2max and Modified BORG scale would be used as an outcome measure tools for cardiovascular parameters and dyspnea. The collected data will be analyzed in SPSS 25.0. Descriptive and inferential statistics will be applied after testing normality of data

Conditions
Prehypertension
Being tested
Moderate-Intensity continuous training
Keywords
Hypertension, Dyspnea, Pilates Training, Modified-Intensity Training
Medical subject headings
Prehypertension, Hypertension, Dyspnea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Moderate-Intensity continuous trainingCombination product

    refers to a type of aerobic exercise that involves maintaining a steady and moderate level of physical activity for an extended period. The exercise is performed at a consistent and moderate pace without significant fluctuations in intensity. MICT primarily targets the aerobic energy system, enhancing cardiovascular endurance and respiratory efficiency

Study groups in NCT06762262
Study groupRoleWhat they receive
Treatment GroupExperimentalModerate-Intensity continuous training (MICT) refers to a type of aerobic exercise that involves maintaining a steady and moderate level of physical activity for an extended period. The exercise is performed at a consistent and moderate pace without significant fluctuations in intensity. MICT primarily targets the aerobic energy system, enhancing cardiovascular endurance and respiratory efficiency
Receives: Combination Product: Moderate-Intensity continuous training
ControlledOtherWill receive Pilates exercises, Mild stretching, Glute Bridge, Isometric Glute Bridge, Single Leg Raise, Upper Abdominal Curl, Single- leg Strech, Double-Leg Strech, Plank Push Backs, roll down, Cool down. Pilates exercises emphasize controlled movements, proper breathing, and the engagement of the deep core muscles. Pilates exercises can be performed on a mat or using specialized equipment such as a reformer.
Receives: Combination Product: Moderate-Intensity continuous training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 6 MWT

    Measured: 8 weeks

  2. VO2 max

    Measured: 8 weeks

  3. Borg Dyspnea Scale

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2025
  2. Study start20 Apr 2024
  3. Primary completion30 Dec 2024 (estimated)
  4. Study completion30 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06762262
Sponsor's protocol ID
Rabbia Naseer Ahmed
Status last verified
Jan 2025
First submitted
1 Jan 2025
Last updated
7 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Moderate-Intensity continuous training in people with Prehypertension, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

6 MWT (time frame: 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in